UK markets close in 3 hours 31 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2921+0.0216 (+7.99%)
At close: 04:00PM EST
0.2800 -0.01 (-4.14%)
Pre-market: 07:00AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2222
Avg. Estimate-0.14-0.12-0.61-0.45
Low estimate-0.15-0.13-0.62-0.52
High estimate-0.14-0.12-0.6-0.38
Year ago EPS-0.4-0.35-1.7-0.61
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2222
Avg. Estimate48.35M46.93M285.77M199.4M
Low estimate46.58M44.87M284M188.47M
High estimate50.12M49M287.54M210.32M
Year ago sales59.6M61.7M213.58M285.77M
Sales growth (year/est)-18.90%-23.90%33.80%-30.20%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.33-0.29-0.31-0.15
Actual EPS-0.4-0.350.15-0.28
Difference-0.07-0.060.46-0.13
Surprise %-21.20%-20.70%148.40%-86.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.14-0.12-0.61-0.45
7 days ago-0.14-0.12-0.61-0.45
30 days ago-0.15-0.11-0.51-0.42
60 days ago-0.15-0.11-0.51-0.42
90 days ago-0.15-0.11-0.51-0.42
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.65.00%N/AN/AN/A
Next qtr.65.70%N/AN/AN/A
Current year64.10%N/AN/AN/A
Next year26.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A